MapLight Therapeutics (MPLT) Other Non-Current Assets (2024 - 2025)
MapLight Therapeutics (MPLT) reported Other Non-Current Assets of $207000.0 for Q4 2025, little changed on a YoY basis from $207000.0 in Q4 2024, and little changed sequentially from $207000.0 in Q3 2025.
MapLight Therapeutics (MPLT) Other Non-Current Assets (2024 - 2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 2 years of Other Non-Current Assets data on file, last reported at $207000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $207000.0; the trailing twelve-month figure through Dec 2025 stood at $207000.0 (changed 0.0% YoY), and the FY2025 full-year result was $207000.0, changed 0.0% from the prior year.
- Other Non-Current Assets steadied at $207000.0 in Q4 2025, from $207000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $207000.0 in Q4 2024 to a low of $207000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | MapLight Therapeutics | 305.82 Mn | 305.82 Mn | - | 207,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 207,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Dec 31, 2024 | 207,000.00 |